|
Back to TSE Homepage
24 March 2003
Post-mortem Tests for BSE in Cattle:
Further Correspondence with Prof Wilesmith
(Filed 24 March 2003)
© www.land-care.org.uk
In view of the greatly improved figures for BSE
in the UK cattle heard, the Food Standards Agency (FSA) announced
that it was considering ways whereby the Over Thirty Months Scheme
(OTMS) for cattle could be relaxed or abandoned (1).
Land-Care published a follow-up article (2)
which included correspondence with Prof Neil Ferguson and Prof John
Wilesmith.
The present article publishes further correspondence
between the Editor of Land-Care and Prof Wilesmith. Land-Care is
most grateful to Prof Wilesmith for responding so promptly and clearly.
|
Friday 21 March 2003
Dear Professor Wilesmith
Tests for BSE
I would like to thank you for your help
with the points raised by Land-Care. Your informative response
is much appreciated.
In writing the follow-up article on the
FSA debate concerning OTMS, I have made the comment:
When assessing the practical application of a test,
it would be standard practice in the field of clinical medicine
to do the assessment in two stages. The first stage would
be to do what is described in ref 3, whereby known positive
and negative samples were sent to participating laboratories.
The second stage would be to see how the tests actually
work out in routine practice. What seems to me to be lacking
is any documented evidence of the latter. Many tests behave
well under test conditions, but fail to live up to expectations
when all the hassles, inconveniences and slip-ups of routine
practice come into play.
Are there any references as to how the three
recommended post-mortem tests perform in routine practice?
Again, thank you for your interest.
Regards
Dr James Irvine
Editor www.land-care.org.uk
Email: editor@land-care.org.uk
|
|
Reply from Prof Wilesmith
21 March 2003
Dear Dr Irvine
Thank you for your E-mail and relating
your comment to me.
I agree with the latter and indeed as a
lab we have done this and I categorise this as examining the
robustness of the diagnostic method. We obviously have an
enormous archive of material to examine the robustness of
the current methods as well as examining the results of the
prospective surveillance in this respect.
In my experience little is published on
this aspect and sometimes this is because various commercial
confidential issues emerge. I doubt that the results of our
work which is the responsibility of our Biotechnology Transfer
Unit will be published, but we have selected the tests we
use on their robustness and not just the results of evaluations.
The EC is about to approve two further tests
at least and they have extended their basic evaluation to
include an examination of the performance of one of the more
technically complex methods in various labs around Europe,
quite an undertaking as it has involved transporting the equipment
around the labs. I expect that this work will be published
if only on the website.
I am sorry that I cannot provide any published
literature from our work.
With best wishes.
John Wilesmith
Head of the Epidemiology Department
Veterinary Laboratories Agency (Weybridge)
New Haw
Addlestone
Surrey
KT15 3NB
Fax No: +1932 349983
Tel: + 1932 357 618
|
Comment
The FSA wish to consult with the public as to
what should be done about the OTMS: that is to say, to what extent
it can be relaxed. Essential to such a debate is clarity of the
evidence put forward for the public to consider. It would be easier
for the public to respond if the basis for the epidemiological models
being used were properly explained, rather than that they will be
told in a few months time. The excuse that such matters are awaiting
peer review and then publication in scientific journals, should
not hold today. With regard to science of major significance to
the welfare of the public (and indeed to the Treasury), it should
not now be overly difficult to get a peer-review done promptly -
a matter of days or weeks. Thereafter, the paper or papers can be
published on-line - again within days - whilst preserving intellectual
property rights.
If the public are to be convinced that the present
system for testing for BSE is sufficient to ensure that older UK
cattle can now safely enter the food chain, convincing documentation
should be available in the public domain to that effect. That means
peer-reviewed presentation of the analysis of tests that are in
the second stage of assessment: i.e. how do they perform in routine
practice.
These are the standards that apply in human clinical
and laboratory medicine. I see no reason why they should be different
for matters relating to the Food Standards Agency.
© www.land-care.org.uk
References
1. Irvine, James
(2003). The Food Standards Agency reviews the OTMS rule - are they
going to scrap it?
(Filed 12 March 2003, www.land-care.org.uk,
click here to view).
2. Irvine, James
(2003). Food Standards Agency Review of OTMS: a follow up.
(Filed 12 March 2003, www.land-care.org.uk,
click here to view).
Further Reading Recommended by Land-Care
Irvine, James (2003). Where has UK Biotechnology Gone?
(Filed 21 March 2003, www.land-care.org.uk,
click
here to view).
Detection of Prions: Developing Technology
(Filed 12 March 2003, www.land-care.org.uk,
click
here to view).
|